

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Tazemetostat is a targeted cancer medication that blocks specific proteins involved in cancer cell growth. It belongs to a newer class of cancer drugs called EZH2 inhibitors, which work by stopping cancer cells from multiplying and spreading.
This medication represents a significant advancement in personalized cancer treatment. Unlike traditional chemotherapy that affects all rapidly dividing cells, tazemetostat specifically targets cancer cells with certain genetic characteristics, making it a more precise treatment option.
Tazemetostat is primarily used to treat two specific types of blood cancers. The medication is approved for epithelioid sarcoma, a rare soft tissue cancer, and follicular lymphoma, a type of non-Hodgkin's lymphoma.
For epithelioid sarcoma, doctors prescribe tazemetostat when the cancer has spread to other parts of the body or cannot be surgically removed. This gives patients with limited treatment options a new avenue for managing their condition.
In follicular lymphoma cases, the medication is used when the cancer has a specific genetic change called an EZH2 mutation. Your doctor will test your cancer cells to determine if this mutation is present before recommending tazemetostat.
The medication is also being studied for other types of cancers in clinical trials. Your oncologist can discuss whether tazemetostat might be appropriate for your specific situation.
Tazemetostat works by blocking an enzyme called EZH2 that cancer cells use to grow and survive. Think of EZH2 as a switch that turns off genes responsible for controlling cell growth - when this switch gets stuck in the "off" position, cells can grow uncontrollably.
By inhibiting EZH2, tazemetostat helps restore normal cell growth control mechanisms. This action can slow down or stop cancer cell multiplication, potentially shrinking tumors or preventing them from growing larger.
The medication is considered a moderately potent cancer treatment. While it's not as intensive as traditional chemotherapy, it can still cause significant side effects and requires careful monitoring by your healthcare team.
What makes tazemetostat particularly valuable is its specificity. It primarily affects cancer cells with EZH2 overactivity, which means it may cause fewer side effects than broader-acting cancer treatments.
Tazemetostat comes as oral tablets that you take twice daily, approximately 12 hours apart. Your doctor will determine the exact dosage based on your specific condition, body weight, and overall health status.
You can take the tablets with or without food, but try to take them at the same times each day to maintain consistent levels in your bloodstream. Swallow the tablets whole with a glass of water - don't crush, chew, or break them.
If you have trouble swallowing pills, talk to your healthcare provider about alternatives. They may be able to provide strategies to make taking the medication easier, but the tablets should remain intact when swallowed.
It's important to take tazemetostat exactly as prescribed, even if you start feeling better. Stopping the medication early or missing doses can reduce its effectiveness in controlling your cancer.
The duration of tazemetostat treatment varies significantly from person to person. Most patients continue taking the medication as long as it's controlling their cancer and the side effects remain manageable.
Your oncologist will regularly monitor your progress through blood tests, imaging scans, and physical examinations. These check-ups help determine whether the medication is working effectively and whether you're tolerating it well.
Some patients may take tazemetostat for months, while others might continue treatment for years. The decision to stop or continue depends on factors like how well your cancer is responding, your overall health, and any side effects you experience.
Never stop taking tazemetostat without discussing it with your healthcare team first. They need to carefully evaluate your situation and may need to adjust your treatment plan gradually.
Like all cancer medications, tazemetostat can cause side effects, though not everyone experiences them. Most side effects are manageable with proper medical support and monitoring.
Here are the most common side effects that patients typically experience:
These common side effects often improve as your body adjusts to the medication. Your healthcare team can provide strategies and medications to help manage these symptoms effectively.
More serious side effects can occur, though they're less common. These require immediate medical attention and include:
Rare but serious side effects include the development of secondary cancers, severe blood disorders, and significant organ dysfunction. Your doctor will monitor for these complications through regular blood tests and examinations.
Contact your healthcare provider immediately if you experience any concerning symptoms. Early intervention can often prevent minor side effects from becoming more serious problems.
Tazemetostat isn't suitable for everyone, and certain medical conditions or situations may make it unsafe. Your doctor will carefully evaluate your health history before prescribing this medication.
You should not take tazemetostat if you're allergic to the medication or any of its ingredients. Signs of allergic reactions include severe rash, difficulty breathing, or swelling of the face, lips, tongue, or throat.
Pregnant women should not use tazemetostat as it can harm the developing baby. If you're of childbearing age, you'll need to use effective birth control during treatment and for several months after stopping the medication.
People with severe liver or kidney disease may not be able to take tazemetostat safely. The medication is processed through these organs, and impaired function can lead to dangerous accumulation of the drug in your system.
If you have a history of blood disorders, immune system problems, or are taking medications that suppress your immune system, your doctor will need to carefully weigh the risks and benefits of tazemetostat treatment.
Tazemetostat is sold under the brand name Tazverik in the United States and many other countries. This is currently the only commercially available form of the medication.
When discussing your treatment with healthcare providers or insurance companies, you might hear both names used interchangeably. Whether referred to as tazemetostat or Tazverik, they're the same medication.
Generic versions of tazemetostat are not yet available. This means Tazverik is currently the only option for patients who need this specific medication.
Treatment alternatives to tazemetostat depend on your specific type of cancer and individual circumstances. For epithelioid sarcoma, other options might include different targeted therapies, immunotherapy, or traditional chemotherapy regimens.
In follicular lymphoma cases, alternatives could include other targeted medications, immunotherapy drugs, radiation therapy, or stem cell transplantation. The best alternative depends on factors like previous treatments, cancer characteristics, and your overall health.
Clinical trials might offer access to experimental treatments that aren't yet widely available. Your oncologist can help you explore whether any ongoing research studies might be appropriate for your situation.
The decision about alternatives should always be made in close consultation with your healthcare team. They can evaluate the potential benefits and risks of each option based on your specific medical situation.
Comparing tazemetostat to other cancer medications isn't straightforward because it treats specific types of cancer with particular genetic characteristics. It's not necessarily "better" than other treatments, but rather more appropriate for certain situations.
For patients with EZH2-mutated follicular lymphoma, tazemetostat may offer advantages over traditional chemotherapy because it targets the specific genetic abnormality driving the cancer. This can mean fewer side effects and potentially better outcomes.
However, for other types of cancer or patients without the specific genetic markers, different medications might be more effective. The "best" treatment is always the one that's most appropriate for your particular cancer and circumstances.
Your oncologist will consider factors like your cancer type, genetic characteristics, previous treatments, overall health, and personal preferences when determining the most suitable treatment approach.
Is Tazemetostat Safe for People with Heart Disease?
Tazemetostat can be used in people with heart disease, but it requires careful monitoring. The medication doesn't directly affect heart function, but cancer treatment can put additional stress on your cardiovascular system.
Your cardiologist and oncologist will work together to ensure your heart condition is stable before starting treatment. They'll also monitor you closely throughout treatment to watch for any changes in your heart health.
If you have heart disease, make sure both your cancer doctor and heart doctor know about all your medications and treatments. This coordination helps ensure the safest possible care.
What Should I Do if I Accidentally Take Too Much Tazemetostat?
If you accidentally take more tazemetostat than prescribed, contact your healthcare provider or poison control center immediately. Taking too much can increase the risk of serious side effects.
Don't wait to see if you feel symptoms - get medical advice right away. The healthcare team can assess the situation and determine if any monitoring or treatment is needed.
To prevent accidental overdoses, consider using a pill organizer or setting phone reminders. Keep the medication in its original container with clear labeling, and never double up on doses.
What Should I Do if I Miss a Dose of Tazemetostat?
If you miss a dose of tazemetostat, take it as soon as you remember, unless it's almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular schedule.
Never take two doses at the same time to make up for a missed dose. This can increase your risk of side effects without providing additional benefit.
If you frequently forget doses, talk to your healthcare team about strategies to help you remember. Consistent dosing is important for the medication to work effectively.
When Can I Stop Taking Tazemetostat?
You should only stop taking tazemetostat when your oncologist determines it's appropriate to do so. This decision is based on how well the medication is controlling your cancer and how well you're tolerating any side effects.
Some patients may stop treatment if their cancer progresses despite the medication, while others might discontinue due to intolerable side effects. Your doctor will help you weigh these factors.
The decision to stop treatment is complex and individualized. Your healthcare team will consider your cancer response, quality of life, and overall health when making this important decision together with you.
Can I Take Tazemetostat with Other Medications?
Tazemetostat can interact with certain medications, so it's crucial to tell your healthcare provider about all drugs, supplements, and herbal products you're taking. Some interactions can affect how well tazemetostat works or increase side effects.
Medications that affect liver enzymes can particularly impact tazemetostat levels in your body. Your doctor may need to adjust dosages or monitor you more closely if you're taking interacting medications.
Always check with your healthcare team before starting any new medications, including over-the-counter drugs and supplements. This includes vitamins, herbal remedies, and even common medications like antacids or pain relievers.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.